GlassScriptPhysician profile
Chase Luther
NPI 1245600691
$4,318.22
in general payments reported to CMS, 2019-2025
30 companies · $1,389 in 2025
The $1,389 reported for 2025 was more than what 90% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $411 · 2022: $456 · 2023: $928 · 2024: $1,134 · 2025: $1,389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,352 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,351.54 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,368.75 | 2021-2025 | Stravix, Grafix Pl, Oasis |
| Urogen Pharma, INC. | $489.29 | 2023-2025 | Jelmyto |
| Merck Sharp & Dohme LLC | $245.31 | 2023-2025 | Keytruda, Lynparza |
| Astellas Pharma US INC | $227.87 | 2023-2025 | Xtandi |
| Sumitomo Pharma America, INC. | $227.35 | 2023-2025 | Orgovyx, Gemtesa |
| Boston Scientific Corporation | $217.68 | 2024-2025 | Ams 700, General - Erectile Dysfunction, Lithovue |
| Teleflex LLC | $176.41 | 2023-2024 | Urolift |
| Endo Pharmaceuticals INC. | $156.92 | 2023-2024 | Xiaflex, Aveed, Edex |
| Baxter Healthcare | $141.21 | 2024 | Tisseel |
| Integra Lifesciences Corporation | $120.48 | 2021 | |
| Antares Pharma, INC. | $116.53 | 2023-2025 | Xyosted, Nocdurna, Tlando |
| Tolmar, INC. | $97.80 | 2023-2025 | Eligard, Jatenzo |
| Janssen Biotech, INC. | $83.59 | 2025 | Carvykti, Rybrevant, Erleada |
| Endo USA, INC. | $77.11 | 2024-2025 | Xiaflex |
| Janssen Scientific Affairs, LLC | $71.58 | 2023 | Balversa, Pipeline, Erleada |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunitybio, INC. | $59.45 | 2025 | |
| Kci USA, INC. | $59.34 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.82 | 2023-2025 | |
| Progenics Pharmaceuticals, INC. | $52.75 | 2023-2024 | Pylarify |
| Procept Biorobotics Corporation | $52.50 | 2024 | Aquabeam System |
| Accord Healthcare, INC. | $47.15 | 2023-2025 | |
| Pfizer INC. | $36.61 | 2024-2025 | |
| Calyxo, INC. | $23.10 | 2025 | Cvac Aspiration System |
| Dendreon Pharmaceuticals LLC | $22.82 | 2023 | Provenge |
| Halozyme INC | $18.58 | 2023 | |
| Abbvie INC. | $17.49 | 2025 | |
| Olympus America INC. | $15.74 | 2023 | Itind System |
| Ferring Pharmaceuticals INC. | $14.60 | 2025 | Adstiladrin |
| Sun Pharmaceutical Industries INC. | $13.33 | 2024 | |
| Axonics, INC. | $13.06 | 2023 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chase Luther listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.